Keyphrases
2,3-butanedione Monoxime
100%
Action Potential Duration
27%
Arrhythmia
72%
Arrhythmia Mechanisms
9%
Arrhythmogenesis
100%
Cytochalasin D
100%
Dominant Frequency
9%
Electric Shock
9%
Electrical Activity
9%
Epicardium
9%
Excitation-contraction
18%
Mapping Method
9%
Monomorphic Ventricular Tachycardia
9%
No Significant Difference
18%
Optical Mapping
9%
Phase number
9%
Phase Singularity
9%
Polymorphic Ventricular Tachycardia
9%
Rabbit Heart
9%
Repolarization
18%
Repolarization Heterogeneity
9%
Restitution Curve
18%
Shock
9%
Shock-induced
100%
Tachycardic
9%
Two-agent
9%
Uncoupler
18%
Ventricular Lead
9%
Ventricular Tachycardia
9%
Window of Vulnerability
9%
Medicine and Dentistry
Action Potential Duration
27%
Arrhythmogenesis
100%
Cardiac Dysrhythmia
81%
Cytochalasin D
100%
Diacetyl Oxime
100%
Electric Shock
9%
Epicardium
9%
Monomorphic Ventricular Tachycardia
9%
Optical Vortex
9%
Polymorphic Ventricular Tachycardia
9%
Repolarization
27%
Shock (Circulatory)
100%
Ventricular Tachycardia
9%
Pharmacology, Toxicology and Pharmaceutical Science
Arrhythmogenesis
100%
Cytochalasin D
100%
Diacetyl Oxime
100%
Electric Shock
9%
Heart Arrhythmia
81%
Heart Ventricle Tachycardia
9%
Leporidae
9%
Monomorphic Ventricular Tachycardia
9%
Polymorphic Ventricular Tachycardia
9%